These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11523315)

  • 1. Long-term treatment with enalapril or losartan does not show antiproliferative effects in peripheral blood mononuclear cells.
    Petrov VV; Fagard RH; Lijnen PJ
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):149-52. PubMed ID: 11523315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans.
    Petrov VV; Fagard RH; Lijnen PJ
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):578-83. PubMed ID: 11588528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
    Verdecchia P; Schillaci G; Reboldi GP; Sacchi N; Bruni B; Benemio G; Porcellati C
    Blood Press Monit; 2000 Jun; 5(3):187-93. PubMed ID: 10915233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
    Byyny RL; Merrill DD; Bradstreet TE; Sweet CS
    Cardiovasc Drugs Ther; 1996 Jul; 10(3):313-9. PubMed ID: 8877074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
    Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
    J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Int J Clin Pharmacol Ther; 2009 Aug; 47(8):525-32. PubMed ID: 19640361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
    Tikkanen I; Omvik P; Jensen HA
    J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.
    Nawarskas JJ; Townsend RR; Cirigliano MD; Spinler SA
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):784-9. PubMed ID: 10480471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension.
    Ruff D; Gazdick LP; Berman R; Goldberg AI; Sweet CS
    J Hypertens; 1996 Feb; 14(2):263-70. PubMed ID: 8728306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term enalapril and losartan therapy of hypertension on cardiovascular aldosterone.
    Li S; Wu P; Zhong S; Guo Z; Lai W; Zhang Y; Liang X; Xiu J; Li J; Liu Y
    Horm Res; 2001; 55(6):293-7. PubMed ID: 11805434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients.
    Azizi M; Linhart A; Alexander J; Goldberg A; Menten J; Sweet C; Ménard J
    J Hypertens; 2000 Aug; 18(8):1139-47. PubMed ID: 10954007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.
    Yee KM; Struthers AD
    Br J Clin Pharmacol; 1998 Dec; 46(6):583-8. PubMed ID: 9862248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
    Dukacz SA; Kline RL
    J Hypertens; 1999 Sep; 17(9):1345-52. PubMed ID: 10489114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
    Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
    J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of losartan and enalapril on erythropoiesis and renal function in hypertensive patients with renal parenchymal disease.
    Shand BI; Lynn KL
    Clin Nephrol; 2000 Nov; 54(5):427-8. PubMed ID: 11105808
    [No Abstract]   [Full Text] [Related]  

  • 20. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
    Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
    Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.